MDXG Q1 2019 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$666M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$67M-20.9% YoY

Gross Profit

$59M88.9% margin

Operating Income

-$13M-20.2% margin

Net Income

-$13M-19.9% margin

EPS (Diluted)

$-0.12

QoQ Revenue Growth

-28.1%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$16M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$107M

Total Liabilities

$69M

Stockholders' Equity

$38M

Cash & Equivalents

$28M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$67M	$84M	-20.9%
Gross Profit	$59M	$75M	-20.9%
Operating Income	-$13M	$3M	-551.5%
Net Income	-$13M	$5M	-387.4%